FDA is expected to authorize Johnson & Johnson's coronavirus vaccine for emergency use in the United States later today, but is the vaccine truly safe and effective? Advisory Board's Brandi Greenberg once again dives deep into the details—including how Johnson & Johnson's vaccine stacks up to Pfizer's and Moderna's vaccines authorized late last year.
The recent decline in new U.S. coronavirus cases and hospitalizations is easing an immense strain on hospitals, but experts say Americans still need to take urgent steps to prevent another surge in the epidemic.
FDA says the Pfizer and BioNTech Covid-19 vaccine can be stored for up to two weeks at temperatures achievable in typical pharmaceutical freezers, NIH announces plans to study long-term Covid-19 symptoms, and more.
Despite a rocky start to the U.S. vaccine rollout, data suggests the United States is doing better than most nations at distributing vaccines—and experts say America's rollout could improve dramatically in the months to come. Daily Briefing's Ashley Fuoco Antonelli details the setbacks and successes of the U.S. rollout so far.
The White House on Wednesday announced the federal government will ship more than 25 million cloth masks to community health centers, food pantries, and soup kitchens, in today's bite-sized hospital and health industry news from the District of Columbia and Rhode Island.
Print All Daily Briefing Article from
02/26/2021
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
